共查询到20条相似文献,搜索用时 171 毫秒
1.
以4-氟苯甲酸为原料,经过酯化、肼解、关环生成5-(4-氟苯基)-1,3,4-噁二唑-2-硫酮,再与溴乙酸乙酯、水合肼反应得到中间体2-[(4-氟苯基)-1,3,4-噁二唑-2-硫基]-乙酰肼,最后中间体酰肼与取代苯甲醛在冰乙酸中回流得到一系列含有1,3,4-噁二唑环的乙酰腙类化合物。目标化合物结构经元素分析、IR、1H NMR、ESI-MS得到确证,并通过K-B纸片法初步测定了它们的生物活性。结果表明,部分化合物具有一定的抑菌活性。 相似文献
2.
利用基团拼合原理,将2,2′-联吡啶和硫醚结构引入到1,3,4-噁二唑母体结构中.以1,10-菲罗啉为原料,经过氧化、酯化、肼解以及环合等化学反应,合成了中间体2,2′-联吡啶-3,3′-二甲酰肼、2,2′-联吡啶-3,3′-二(5-[1,3,4-噁二唑-2-硫酮])以及4个2,2′-联吡啶-3,3′-二(5-[1,3,4-噁二唑-2-硫醚])系列目标化合物,其结构通过1 H NMR和单晶X-射线衍射等进行表征.晶体结构分析表明:2,2′-联吡啶的3和3′位上取代基不同,2个吡啶环所在平面的偏转角度不同,1,3,4-噁二唑-2-硫醚结构能使2个吡啶环呈现较大的偏转角度. 相似文献
3.
利用生物活性亚结构拼接原理,将吡啶环、噻唑环引入到1,3,4-噁二唑母体结构中,设计并合成了一系列新型含吡啶(噻唑)的1,3,4-噁二唑衍生物.通过IR,1H NMR,EI-MS及元素分析等方法对所合成的化合物进行了结构表征.代表化合物2-(6-氯吡啶-3-甲硫基)-5-(吡啶-4-基)-1,3,4-噁二唑(I)经单晶X衍射证实了结构.初步测定了所合成化合物的杀菌活性,并比较了在1,3,4-噁二唑母体结构中引入噻唑杂环和引入吡啶杂环后其杀菌活性的差异.结果表明:目标化合物对测试的5种菌均具有一定的杀菌活性,对水稻纹枯病的抑制效果普遍优于对其它菌种的抑制效果;在1,3,4-噁二唑母体结构中引入噻唑杂环比引入吡啶杂环对其杀菌活性更有利. 相似文献
4.
在KOH作用下,芳甲酰肼1a~1e与CS2环化生成5-芳基-2-巯基-1,3,4-噁二唑(2a~2e);将2a~2e与氯乙酸乙酯反应,生成2-(5-芳基-1,3,4-噁二唑)硫基乙酸乙酯(3a~3e);3a~3e肼解得2-(5-苯基-1,3,4-噁二唑-2-硫基)乙酰肼(4a~4e);4a~4e与芳酰基异硫氰酸酯5a~5d反应得到双酰基氨基硫脲衍生物A1~A19;A1~A19在H2SO4催化下环合得到目标化合物B1~B19;目标化合物的结构经IR,1H NMR,MS,HRMS确证. 相似文献
5.
6.
以苯并咪唑-2-甲酸、水合肼、取代苯基异硫氰酸酯和取代苯甲酸等为原料,经多步反应合成了16种2-(苯并咪唑-2-基)-5-取代苯基-1,3,4-噁二唑和2-(苯并咪唑-2-基)-5-取代苯胺基-1,3,4-噁二唑新化合物,并考察了微波辐射对反应的影响.产物结构利用IR,1H NMR,13C NMR和元素分析确证.用生长速率法测试了目标化合物对番茄灰霉病菌和小麦菌核病菌的离体抑制活性,结果表明3种化合物对番茄灰霉病菌有很高的抑制活性,其EC50分别为2.55,6.34和5.12μg/mL,活性高于对照药剂多菌灵(EC50=7.40μg/mL). 相似文献
7.
2-取代氨基-5-去氢枞基-1,3,4-噁二唑衍生物的合成及除草活性 总被引:2,自引:0,他引:2
以去氢枞酸为原料,经酰化后与水合肼反应合成去氢枞酰肼3,再与芳基异硫氰酸酯反应,得到中间体1-去氢枞酰基-4-取代基氨基硫脲4,4在Hg(OAc)2/EtOH条件下关环,合成得到一系列新型2-取代氨基-5-去氢枞基-1,3,4-噁二唑化合物5.采用IR,MS,1HNMR,13C NMR和元素分析等方法对中间体4和目标产物5进行了分析和表征.初步的除草活性测试表明,化合物4和5对油菜的胚根生长以及对稗草的幼苗生长有一定的抑制作用,其中化合物4d在浓度为100mg/L时对油菜胚根生长的抑制率达88.2%. 相似文献
8.
将2-巯基-5-取代基-1,3,4-噻二唑经与β-氯苯丙酮取代、盐酸羟胺肟化和氯甲基噁二唑醚化,合成了6种3-(5-取代基-1,3,4-噻二唑-2-硫代基)-1-苯基丙酮-O-(5-苯基-1,3,4-噁二唑-2-甲基)肟醚化合物(4a~4f),用1H NMR、IR、MS和元素分析表征了其结构。 用MTT法测试了6种目标化合物对人黑色素瘤细胞株B16、人白血病细胞株HL60和人肝癌细胞株SMMC-7721的体外细胞毒活性。 测试结果表明,部分化合物对3种癌细胞具有潜在的体外生长抑制活性。 相似文献
9.
继2,6-二取代苯并二噁唑、2,5-二取代噁唑和2,5-二取代噁二唑及1,4-二(苯并噁唑-1,3基-2)苯等系列化合物合成及光性能研究后,又合成了双荧光发色团化合物2-(ω-联苯基多亚甲基)-5-联苯基噁唑-1,3和2-(ω-联苯基多亚甲基)-5-联苯基噁二唑-1,3,4共七种化合物。 相似文献
10.
11.
The bis[4-aryl-3-alkylthio-1,2,4-triazol-5-yl]alkanes 4 were prepared by the action of alkyl halides on bis[4-aryl-1,2,4-triazoline-5-thione-5-yl]alkanes in aqueous sodium hydroxide (5%). The prepared sulphides 4 were oxidised to give the corresponding sulphones 5 either with acidic potassium permanganate or hydrogen peroxide. Similarly, sulphides 8 were prepared from 5-phenyl-1,3,4-oxadiazole-2-thione by reaction with different alkylhalides in alkaline medium. Mannich bases 9 from 5 -phenyl-1,3,4-oxadiazole-2-thione (7) were also prepared by stirring an equimolar solution of 6 in ethanol with formaldehyde (38%) and an amine in an ice-cold bath. All the compounds were screened for their pesticidal activities but none showed any significant activity. 相似文献
12.
Romualdas Smicius Virginija Jakubkiene Milda M. Burbuliene Povilas Vainilavicius 《Monatshefte für Chemie / Chemical Monthly》2002,7(1):173-181
Treatment of 5-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-3-pyrimidinyl)-methyl-1,3,4-oxadiazole-2-thione with haloalkanes yielded oxadiazole S-alkyl derivatives, whereas its reaction with formaldehyde and amines resulted in formation of oxadiazole N(3)-aminomethyl derivatives. The alkylation of 2-alkylsulfanyl-5-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-3-pyrimidinyl)-methyl-1,3,4-oxadiazoles with methyl bromoacetate proceeded at the N(1)-position of pyrimidine to give 2-alkylsulfanyl-5-(1-methoxycarbonylmethyl-6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-3-pyrimidinyl)-methyl-1,3,4-oxadiazoles, whereas aminomethylation, bromination, or nitration took place at position 5 of pyrimidine ring and afforded the corresponding 5-pyrimidine substituted derivatives. 相似文献
13.
Various 1,2,4-triazoles and 1,3,4-oxadiazole derivatives have been reported to possess diverse biological activities.In addition to above biological activity, we coupled these two rings together to get 1,2,4-triazolo[3,4-b] 1,3,4-oxadiazole derivatives. This ring system was first reported in 1961[1] and synthesized in 1971. 相似文献
14.
Romualdas Smicius Virginija Jakubkiene Milda M. Burbuliene Povilas Vainilavicius 《Monatshefte für Chemie / Chemical Monthly》2002,133(2):173-181
Summary. Treatment of 5-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-3-pyrimidinyl)-methyl-1,3,4-oxadiazole-2-thione with haloalkanes yielded
oxadiazole S-alkyl derivatives, whereas its reaction with formaldehyde and amines resulted in formation of oxadiazole N(3)-aminomethyl
derivatives. The alkylation of 2-alkylsulfanyl-5-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-3-pyrimidinyl)-methyl-1,3,4-oxadiazoles
with methyl bromoacetate proceeded at the N(1)-position of pyrimidine to give 2-alkylsulfanyl-5-(1-methoxycarbonylmethyl-6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-3-pyrimidinyl)-methyl-1,3,4-oxadiazoles,
whereas aminomethylation, bromination, or nitration took place at position 5 of pyrimidine ring and afforded the corresponding
5-pyrimidine substituted derivatives.
Received May 9, 2001. Accepted (revised) August 17, 2001 相似文献
15.
Lamya H. Al-Wahaibi Ahmed A. B. Mohamed Samar S. Tawfik Hanan M. Hassan Ali A. El-Emam 《Molecules (Basel, Switzerland)》2021,26(8)
The reaction of 5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-thione 3 with formaldehyde solution and primary aromatic amines or 1-substituted piperazines, in ethanol at room temperature yielded the corresponding N-Mannich bases 3-arylaminomethyl-5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-thiones 4a–l or 3-[(4-substituted piperazin-1-yl)methyl]-5-(3,4-dimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-thiones 5a–d, respectively. The in vitro inhibitory activity of compounds 4a–l and 5a–d was assessed against pathogenic Gram-positive, Gram-negative bacteria, and the yeast-like pathogenic fungus Candida albicans. The piperazinomethyl derivatives 5c and 5d displayed broad-spectrum antibacterial activities the minimal inhibitory concentration (MIC) 0.5–8 μg/mL) and compounds 4j, 4l, 5a, and 5b showed potent activity against the tested Gram-positive bacteria. In addition, the anti-proliferative activity of the compounds was evaluated against prostate cancer (PC3), human colorectal cancer (HCT-116), human hepatocellular carcinoma (HePG-2), human epithelioid carcinoma (HeLa), and human breast cancer (MCF7) cell lines. The optimum anti-proliferative activity was attained by compounds 4l, 5a, 5c, and 5d. 相似文献
16.
含吡唑环的1,2,4-三唑希夫碱类衍生物的合成及生物活性 总被引:1,自引:0,他引:1
以自制的4-氨基-4,5-二氢-3-[(3,5-二甲基吡唑-1-基)甲基]-1,2,4-三唑-5-硫酮衍生物为中间体, 与取代苯甲醛反应合成了一系列新型含吡唑环的1,2,4-三唑希夫碱衍生物. 通过红外光谱、 核磁共振波谱、 高分辨质谱、 元素分析及X射线单晶衍射对目标化合物进行了结构表征, 并初步测试了其生物活性. 结果表明, 大部分化合物表现出较好的抑菌活性, 其中化合物G9, G10和G15的抑菌效果优于对照药三唑酮. 相似文献
17.
以白杨素为起始原料, 通过卤代和水解反应制得中间产物7-O-羧烷基化的白杨素衍生物(6~9); 然后以1-乙基-3-(3-二甲氨基丙基)碳二亚胺(EDCI)、 1-羟基苯并三氮唑(HOBt)和4-二甲氨基吡啶(DMAP)为催化体系, 4个中间产物分别与甘氨酸甲酯盐酸盐进行酰胺缩合反应, 制得白杨素甘氨酸甲酯类化合物12~15; 化合物12~15在pH=10~11和室温下水解得到相应的白杨素甘氨酸类化合物(16~19). 所有目标化合物的结构均经 1H NMR, 13C NMR, IR以及MS确认. 以顺铂为阳性对照药物, 采用噻唑蓝比色(MTT)法检测了目标化合物对人肝癌细胞HepG2和人胃癌细胞MGC-803的体外增殖抑制作用. 结果表明, 目标化合物14~16, 18和19的体外抗肿瘤活性明显强于白杨素, 且化合物18(IC50=4.36 μmol/L)对MGC-803细胞的增殖抑制作用强于阳性药物顺铂(IC50=4.40 μmol/L). 相似文献
18.
Starting from readily available pyroglutamic esters 1 , some new 1,3,4-oxadiazole-2-thione derivatives, bonded to a pyrrolidinone ring were synthesised and characterised by their spectral data. 相似文献
19.
Eighteen novel triazole compounds containing 1,3,4-oxadiazole groups were synthesized from 2-(1H-1,2,4-triazol-1-yl)acetohydrazide and carbon disulfide by several step reactions. The target compounds were characterized by elemental analysis, 1H NMR, 13C NMR, IR, MS, and X-ray crystallography. The results of preliminary biological tests show that all the compounds exhibit certain fungicidal activities. 相似文献
20.
Wael A. El-Sayed Mohamed I. Hegab Hala E. M. Tolan Adel A.-H. Abdel-Rahman 《Monatshefte für Chemie / Chemical Monthly》2008,139(9):1055-1060
A series of new N- and S-substituted 1,3,4-oxadiazole derivatives were synthesized. 5-Pyridin-3-yl-3-[2-(5-thioxo-4,5-dihydro-l,3,4-thiadiazol-2-yl)ethyl]-1,3,4-oxadiazole-2(3H)-thione and 5-[(5-(pyridin-3-yl)-1,3,4-oxadiazol-2-ylthio)methyl]-N-phenyl-1,3,4-thiadiazol-2-amine were formed by cyclization of 3-(5-pyridin-3-yl-2-thioxo-1,3,4-oxadiazol-3(2H)-ylpropanimidohydrazide and 2-[(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)thio]thiosemicarbazide with CS2 and H2SO4. On the other hand, a number of new bicyclic 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives were synthesized. 6-Pyridin-3-ylbis[1,2,4]‐triazolo[3,4-b:4′,3′-d][1,3,4]thiadiazole-3(2H)-thione was synthesized by reaction of 6-(hydrazino)-3-pyridine-3-yl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole with CS2/KOH/EtOH. The structures of the newly synthesized compounds were elucidated by the spectral and analytical data IR, Mass, and 1H NMR spectra.
Correspondence: Adel A.-H. Abdel-Rahman, Department of Chemistry, Faculty of Science, Menoufia University, Shebin El-Koam,
Egypt; Wael A. El-Sayed, National Research Centre, Department of Photochemistry, Cairo, Egypt. 相似文献